Molecular Mechanism and Application of Somatic Cell Cloning in Mammals

ISBN 10: 3036559663 / ISBN 13: 9783036559667

Published by MDPI AG, 2023

About this Item

nach der Bestellung gedruckt Neuware - Printed after ordering - The primary objective of this book is to provide the current status of and new data on the molecular mechanisms affecting the efficacy of somatic cell cloning, but also insightful interpretations of the topical and coming trends in the exploration of genomic, epigenomic, transcriptomic and proteomic profiles for nuclear donor cells, nuclear recipient oocytes and SCNT-derived embryos. Comprehensively deciphering the crucial molecular scenarios responsible for inter-genomic, inter-epigenomic, inter-transcriptomic and inter-proteomic communication within the framework of the aforementioned scenarios might be a milestone giving rise to the enhancements in the extra- and intracorporeal epigenetic reprogrammabilities of donor cell nuclei in nuclear-transferred oocytes, embryos, conceptuses and neonates. In turn, this might allow us to use SCNT-mediated ARTs in such research fields as biotechnology, transgenics, medicine, and biopharmacology, as well as scientific efforts targeted at designing the in vitro and in vivo models of molecular and epigenomic landscapes specific for inheritable and acquired disorders in humans and other mammalian species.

Seller Inventory # 9783036559667

Bibliographic Details

• Title: Molecular Mechanism and Application of Somatic Cell Cloning in Mammals
• Publisher: MDPI AG
• Publication Date: 2023
• Language: English
• ISBN 10: 3036559663
• ISBN 13: 9783036559667
• Binding: Buch
• Condition: Neu
• Dimensions: 250W x 175H x 20D millimeters 250 millimeters width by 175 millimeters height by 20 millimeters depth
• Weight: 810 grams

About this title

Synopsis

The primary objective of this book is to provide the current status of and new data on the molecular mechanisms affecting the efficacy of somatic cell cloning, but also insightful interpretations of the topical and coming trends in the exploration of genomic, epigenomic, transcriptomic and proteomic profiles for nuclear donor cells, nuclear recipient oocytes and SCNT-derived embryos. Comprehensively deciphering the crucial molecular scenarios responsible for inter-genomic, inter-epigenomic, inter-transcriptomic and inter-proteomic communication within the framework of the aforementioned scenarios might be a milestone giving rise to the enhancements in the extra- and intracorporeal epigenetic reprogrammabilities of donor cell nuclei in nuclear-transferred oocytes, embryos, conceptuses and neonates. In turn, this might allow us to use SCNT-mediated ARTs in such research fields as biotechnology, transgenics, medicine, and biopharmacology, as well as scientific efforts targeted at designing the in vitro and in vivo models of molecular and epigenomic landscapes specific for inheritable and acquired disorders in humans and other mammalian species.